News | April 23, 2025
Cosmo First to acquire veterinary clinic
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
More than 40 types of Amyloid proteins are discovered till date
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Overall investment in the US facility is estimated around US$50 million
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for metastatic breast cancer patients.
Subscribe To Our Newsletter & Stay Updated
